A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Agitation and Aggression in Alzheimer's Disease
Interventions
DRUG

Pimavanserin

Pimavanserin 20 mg, tablet, taken as two 10 mg tablets, once daily by mouth, OR Pimavanserin 34 mg, tablet, taken as two 17 mg tablets, once daily by mouth

Trial Locations (28)

19090

Abington Neurological Associates, Ltd., Willow Grove

20007

Clinical Research Unit, Washington D.C.

28270

ANI Neurology, PLLC dba Alzheimer's Memory Center, Charlotte

31059

CHU de Toulouse - Cite de la sante - Gerontople, Toulouse

33064

Quantum Laboratories Inc., Deerfield Beach

33137

Miami Jewish Health Systems, Miami

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

34105

Collier Neurologic Specialists LLC, Naples

48993

Centro de Atencion Especializada Oroitu, Algorta

50012

Hospital Viamed Montecanal, Zaragoza

75115

Insite Clinical Research, LLC, DeSoto

84107

Pharmaceutical Research Associates, Inc., Salt Lake City

92103

Pacific Clinical Research Network, San Diego

92626

ATP Clinical Research, Inc., Costa Mesa

92835

Neurology Center of North Orange County, Fullerton

93710

Neuro-Pain Medical Center, Fresno

7500710

Biomedica Research Group, Santiago

7560356

Especialidades Medicas L y S, Santiago

04401

Acadia Hospital, Bangor

02169

Alzheimer's Disease Center, Quincy

07724

Memory Enhancement Center of America, Inc., Eatontown

08755

Bio Behavioral Health, Toms River

127-0244

Psicomed Estudios Médicos, Antofagasta

03203

Hospital General Universitario de Elche, Elche

08221

Hospital Universitari Mutua de Terrassa, Terrassa

BA1 3NG

RICE-The Research Institute for the Care of Older People, The RICE Centre, The Royal United Hospital, Bath

TW7 6AF

West London Cognitive Disorders Treatment & Research Unit, Lakeside Mental Health Unit, West Middlesex University Hosp. Site, Isleworth

M8 5RB

Greater Manchester Mental Health NHS Foundation Trust, Manchester

Sponsors
All Listed Sponsors
lead

ACADIA Pharmaceuticals Inc.

INDUSTRY